ADAM ANCEL: Open Payments
NPI 1801242359 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 36 payments from 8 companies in 2025. Trend: 2023 $673 · 2024 $654 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $255 |
| Merz Pharmaceuticals, LLC | 7 | $162 |
| PFIZER INC. | 4 | $81 |
| Bioventus LLC | 2 | $43 |
| Boston Scientific Corporation | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| Vertex Pharmaceuticals Incorporated | 1 | $27 |
| Medtronic, Inc. | 1 | $22 |
Products named: Xeomin, UBRELVY, QULIPTA, NURTEC ODT, WaveWriter Alpha Prime 16, VYEPTI, JOURNAVX, XCELL.
Industry payments across MI — which companies pay providers there.
